next ann:initiation of phase iia trial atl1103, page-10

...and let's remember that ANP is still well and truly a penny stock, so of course we are early in the peace as to where this could go, but the upside potential is there and is being communicated well by management.

I presume most holders are invested here because of the upside.

Its all pretty exciting and for those who have not had too much exposure to Biotechs, it should be an interesting ride - you're certainly in at the right level to benefit medium/long term and as for short term, there is still room for good upward movement.